scientificsessions.org
Exhibits: November 14–16Sessions: November 13–17
Resuscitation Science Symposium: November 13–14
Chicago, Illinois
scientificsessions.orgThe Council on Cardiovascular Radiology and Intervention invites you to attend Scientific Sessions and experience programming dedicated to your specialty!
McCormick Place Convention Center | Chicago, Illinois | Nov. 13–17, 2010
The seven multidisciplinary cardiovascular cores reflect the evolution of scientific investigation and practice; include and integrate basic, clinical, population and translational science; and will increase integration among attendees.
The cores align the meeting content with your areas of interest, helping you better navigate the meeting. Programming of interest will be featured in Cores One and Six.
SUNDAY, NOVEMBER 14
8–11 am INtEgRAtED IMAgINg: INSIghtS fROM REcENt clINIcAl tRIAlS ROMICAT COURAGE Core 64 DIAD Arbiter-6 MESA
IMAgINg Of cORONARY ARtERY DISEASE BEYOND lUMENOgRAphY Imaging Atherosclerosis with CT Plaque Imaging with MRI Invasive Imaging with IVUS and OCT CT Perfusion Imaging MR Perfusion SPECT and PET Perfusion Imaging
ROlE Of MUltIMODAlItY IMAgINg IN DAIlY pRActIcE: A cASE-BASED AppROAch
Myocarditis ARVD Restrictive vs Constrictive Isolated Diastolic Dysfunction Evaluating Tricuspid Regurgitation PCI with No Reflow
MANAgINg thE hEARt fAIlURE pAtIENt: thE ROlE Of IMAgINg Functional Mitral Regurgitation: Role of 3D Echocardiography Imaging of Dysynchrony: Which Technique? Optimal Assessment of Myocardial Viability Structural Left Ventricular Remodeling Evaluation of Cardiac Innervation Assessment of Cardiomyopathy: Role of Magnetic Resonance
3:45–5 pm thE clINIcAl cONUNDRUM: ScREENINg Of ASYMptOMAtIc hIgh-RISk pAtIENtS
Biomarkers and Ankle Brachial Index Carotid Intima-Media Thickness Cardiac CT: Calcium and CTA Silent Ischemia
Scientific Sessions Seven Cardiovascular Cores
Cardiovascular Imaging
Join or renew your AhA/ASA professional Membership today and save! (promo code DAJ103ZZ)
5:30–6:45 pm WhAt IS AN AppROpRIAtE StRESS IMAgINg tESt fOR SUSpEctED ANgINA IN 2010?
Nuclear Imaging: Beyond Perfusion Stress Echocardiography: Wall Motion and Beyond CT Angiography and Myocardial Perfusion: One Stop Test Myocardial Perfusion by CMR: More than Meets the Eye Who Needs to Be Tested and When?
cAN IMAgINg hElp IN thE SElEctION Of pAtIENtS fOR IcD AND cRt? What Does the Electrophysiologist Need from Imaging? The Value of Cardiac MR Is There a Role for CT? The Role of Echocardiography What Can Be Gained from Nuclear Imaging
EchOcARDIOgRAphY IN VAlVUlAR hEARt DISEASE: WhEN tO REfER fOR SURgERY
Tricuspid Regurgitation Mitral Regurgitation Mitral Stenosis Aortic Stenosis Aortic Regurgitation
EMERgINg tEchNOlOgIES IN cARDIOVAScUlAR fUSION IMAgINg MR — Optical Imaging PET — Optical Imaging PET— CT Imaging PET — MR Imaging
MONDAY, NOVEMBER 15
7:45–8:45 am hOW DO I USE 3D EchOcARDIOgRAphY tODAY? Left Ventricular Function Valvular Heart Disease Right Ventricular Function
OptIMAl EchOcARDIOgRAphIc ASSESSMENt Of cARDIAc fUNctION IN 2010
Novel Techniques to Quantify Systolic Function Optimal Assessment of Diastolic Function How to Assess Cardiac Dyssynchrony
cARDIAc cOMpUtED tOMOgRAphY: StAtE Of thE ARt 2010 PET/CT: Future Role Clinical Role of CT in Myocardial Perfusion Noncoronary Cardiac CT
NUclEAR cARDIOlOgY: StAtE Of thE ARt 2010 Innovations in Cardiac SPECT Update: Cardiac PET Update on Radiotracers
2–3:15 pm WhAt IS thE ROlE Of IMAgINg IN cARDIAc RESYNchRONIZAtION thERApY? OptIMISM AND REAlISM
What Do the Clinical Trials Tell Us About Imaging and CRT? Mechanical Dyssynchrony: Do We Know How and What to Image? Myocardial Scar/Viability: Where Does That Fit In? Coronary Venous Anatomy: Another Piece of the Puzzle? Synthesis: How Do I Use Imaging for CRT in 2010?
Register onl ine today at scientif icsessions.org. (promo code DM301)
Join or renew your AhA/ASA professional Membership today and save! (promo code DAJ103ZZ)
5:30–6:45 pm WhAt ShOUlD YOU kNOW ABOUt IMAgINg hEARt DISEASE IN WOMEN?
Vulnerability to Coronary Artery Disease Chest Pain Syndromes Valvular Heart Disease Heart Failure Appropriate Use of Imaging in Women: Gaps in Current Practice
ADVANcED IMAgINg IN ADUltS WIth cONgENItAl hEARt DISEASE Marfan Syndrome Tetraology of Fallot Atrial Septal Defect/Ventricular Septal Defect Transposition of the Great Arteries
NONISchEMIc cARDIOMYOpAthY: ROlE Of cOMpUtED tOMOgRAphY AND MAgNEtIc RESONANcE
Amyloidosis Noncompaction Cardiomyopathy Sarcoidosis Hypertrophic Cardiomyopathy
tUESDAY, NOVEMBER 16
7:45–8:45 am cARDIAc MAgNEtIc RESONANcE: StAtE Of thE ARt 2010 Stress MR for Detecting CAD Contrast-Enhanced MR for Viability MR and Evaluation of Myocardial Disease
VAScUlAR IMAgINg Of thE RENAl cOMpROMISED pAtIENt Catheter-Based Options Optimized CTA MRA: To Gd or Not to Gd
IMAgINg IN pERcUtANEOUS VAlVE thERApY Current Status of Percutaneous Aortic and Mitral Valve Therapy Imaging in Percutaneous Mitral Valve Therapy Imaging in Percutaneous Aortic Valve Therapy
MYOcARDIAl StRAIN IN clINIcAl pRActIcE Predictive Value: Suspectibility to Disease Diagnostic Value: Detecting Overt Disease Prognostic Value: Progression/Regression of Disease
2–3:15 pm IMAgINg VUlNERABIlItY tO cARDIOVAScUlAR DISEASE The Vulnerable Patient: Clinical Profile The Vulnerable Vessel: Vascular Profile The Vulnerable Plaque: Plaque Profile The Vulnerable Myocardium: Myocardial Profile Imaging in the Era of Genes and Biomarkers: Do We Need It?
5:30–6:45 pm INtEgRAtED IMAgINg Of hEARt fAIlURE: clINIcAl UpDAtE 2010 What the Clinician Needs to Know Left Ventricular Size and Ejection Fraction Is Simple and Effective (Echo/CMR) Myocardial Scar and Strain Assessment Is Incremental (CMR/Echo) Myocardial Blood Flow and Metabolism Matters (Nuclear/PET) Molecular Imaging Is the Holy Grail (Nuclear/CT/Echo)
clINIcAl USE Of NOVEl EchOcARDIOgRAphY tEchNOlOgY 3D Echocardiography Contrast Echocardiography Tissue Doppler and Strain Imaging Intracardiac Echocardiography
Register onl ine today at scientif icsessions.org. (promo code DM301)
ROlE Of IMAgINg IN chRONIc tOtAl OcclUSION 2010 What Information Is Needed for Proper Patient Selection? Use of Computed Tomography to Assess the Occluded Artery Is the Tissue Viable? The Role of Nuclear Imaging Viability Assessment by CMR Viability Assessment by Echocardiography
WEDNESDAY, NOVEMBER 17
7:45–8:45 am OptIMAl EVAlUAtION Of AORtIc DISSEctION Are Clinical, ECG and Biomarker Assessments Sufficient? Strengths and Limitations of TEE Strengths and Limitations of CT/CMR
RElEVANcE Of IMAgINg IN DIAStOlIc hEARt fAIlURE Clinical Profile Is Unique Biomarker Profile Clarifies Imaging Profile Confirms
9–10:15 am AhA/NhlBI/ScMR 9th ANNUAl WORkShOp ON cARDIOVAScUlAR INtERVENtIONAl MAgNEtIc RESONANcE
MRI-Guided Electrophysiology 1 Novel Pediatric Procedures Using Real-Time MRI iCMR: Lessons from Radiology and Oncology Faster and More Effective Real-Time MRI MRI Thermometry: Prospects for EP Ablation Monitoring
cARDIOVAScUlAR IMAgINg 2010: WhAt IS thE EVIDENcE fOR clINIcAl pRActIcE?
Coronary Artery Disease Heart Failure Valvular Heart Disease Imaging: Quality, Value and Cost-Effectiveness Future Challenges and Opportunities in Cardiac Imaging
Vascular Disease: Catheter-basedand Surgical Interventions
SAtURDAY, NOVEMBER 13
1–2:15 pm AORtIc VAlVE tREAtMENt: chANgINg pARADIgMS INDIAgNOSIS AND AppROAch
Epidemiology and Pathophysiology of Aortic Stenosis Controversies in Diagnostic Testing and Indications for Valve Replacement Open Aortic Valve Replacement — Still the Gold Standard Patient-Prosthesis Mismatch: Does It Matter? Percutaneous Aortic Valves: Which Valve for Which Patient? Case Study: Percutaneous Challenges in AVR
2:30–3:45 pm pERcUtANEOUS StRUctURAl hEARt INtERVENtIONS StAtE Of thE ARt: AtRIUM, SEptUM, VAlVES AND WEIRD StUff
Percutaneous AVR for Aortic Stenosis: Routine Treatment or High-Risk Patients? Atrial Appendage Occlusion for Atrial Fibrillation: Indications, Technique
and Evolving Technologies PFO and ASD Closure: Current Trials, Indications, Technique and Technology Percutaneous Mitral Valve Repair: If Not Now, When? A Case Study and Panel Discussion: Novel Uses of an Amplatz Occluder Device
4–5:15 pm DRUg-ElUtINg StENtS I: BESt StENt NOW, BESt StENt tOMORROW? The Best DES: Pathology Results The Best DES: A Review of the Comparative Trials The Best DES: Registry Results The Best DES Tomorrow: Bioabsorption Polymers and Stents? Case Presentation: DES Choices in Complex Situations
SUNDAY, NOVEMBER 14
8–11 am clINIcAl cONtROVERSIES: pERcUtANEOUS INtERVENtION OR SURgERY? Patients with Left Main Disease: PCI Now (Pro) Patients with Left Main Disease: PCI Now (Con) Symptomatic Diabetics Require Medical Therapy First Symptomatic Diabetics Require Revascularization First Patients with Critical Limb Ischemia Should Get Endovascular Therapy Patients with Critical Limb Ischemia Should Get Surgical Bypass Aortic Valve Disease: Percutaneous Therapy Will Be Routine Aortic Valve Disease: Surgery Remains the Routine
8 am–NOON INtERVENtIONAl cARDIOlOgY fROM BENch tO BEDSIDE: cONtROVERSY, chAllENgES AND lANDMARk clINIcAl tRIAlS
Session I: controversy in Acute Myocardial Infarction Prevention of Acute MI: We Must Identify the Mild, Soft Culprit Plaque Prevention of Acute MI: The Culprit Is Shifting to the Severe, Bulky Plaque STEMI PCI: Thrombectomy Should Be Routine STEMI PCI: Thrombus Removal Is Not Mandatory STEMI and Longer Transfer Times: A Lytic-Based Pharmacoinvasive PCI
Approach Should Be Routine STEMI and Longer Transfer Time: Be Quick and Forget the Lytics
Session II: the 3 toughest Archived cases in pcI, Structural and Endovascular Intervention
My Most Difficult Case: PCI My Most Difficult Case: Structural Heart My Most Difficult Case: Endovascular
Session III: three high-Impact trials in 2010 — What can We Expect clinically? The CREST Trial: Carotid Stenting Grows? The PLATO Trial: Ticagrelor for All STEMI Patients? The SYNTAX Left Main Analysis: Left Main PCI for Most Patients?
Join or renew your AhA/ASA professional Membership today and save! (promo code DAJ103ZZ)
“�The�AHA�provides�one�of�the�most�multidisciplinary�forums�in�which�interventional�radiology�can�interact�with�disciplines�from�all�parts�of�medicine.�Through�membership�in�the�Council,�we�have�a�“voice�at�the�table”�in�one�of�the�most�important�scientific�organizations�in�the�world.”
Barry Katzen, MD, FAHA
8–11 am cORONARY ARtERY BYpASS INNOVAtIONS All-Arterial Revascularization MIDCAB Advances Hybrid Combined CABG with PCI Current Status of Robotic TECAB On-Pump CABG Is Still the Gold Standard Off-Pump CABG Is the Platinum Standard in Japan Veins Used Correctly Are Still Great Conduits Molecular and Cellular Therapies for Enhancing Vein Graft Patency
3:45–5 pm gREAt DEBAtES IN INtERVENtIONAl cARDIOlOgY Bleeding Complications and PCI: Sex Matters Bleeding Complications and PCI: Sex Is Not the Key Issue Measurement of Platelet Aggregation Inhibition: Clinically Relevant Measurement of Platelet Aggregation Inhibition: Not Ready for Routine Use Multivessel DES PCI: A Current Standard of Care in the Right Groups Bypass Surgery: The Standard of Care for Multivessel CAD
5:30–6:45 pm gRANtSMANShIp WORkShOp NIH “Insider” Insights NIH R01: Specific Aims, Background and Preliminary Data NIH R01: Experimental Design Career Development Awards Foundation Grants
gUIDElINES AND EMERgINg thERApY IN pUlMONARY EMBOlISM Catheter-Based Therapy of Pulmonary Embolism New Medical Therapies for DVT and Pulmonary Embolism The Role of Surgery in Pulmonary Embolism The ESC Guidelines on Treatment of Pulmonary Embolism Case Study: Treatment Choices and Dilemmas
VAD IMplANtAtION tIpS AND tRIckS Extracorporeal Devices Axial Flow Devices Implantable Rotary Devices Animal Models of Ventricular Assist Research Novel Cellular Linings for VADs
5:30–6:45 pm DRUg-ElUtINg StENtS AND NONcARDIAc SURgERY: cURRENt REcOMMENDAtIONS
When Is Preoperative Revascularization Needed? Pathophysiology of Perioperative Stent Thrombosis Perioperative Stent Thrombosis: Defining Incidence, Risk and Timing Current Recommendations for Cessation of Antiplatelet Therapy During
Noncardiac Procedures A Case Study and Panel Discussion: Drug-Eluting Stent and a Needed
Noncardiac Procedure
MONDAY, NOVEMBER 15
7:45–8:45 am AtRIAl fIBRIllAtION SURgERY
hOW tO BUIlD A tRANSRADIAl pRActIcE Starting a Transradial Practice: Access, Set-up, Catheters and Tips Case Review 1: Negotiating the Anatomy Case Review 2: Bifurcations, CTO and Complications from Radial Approach
hOW tO MAxIMAllY UtIlIZE INtRAOpERAtIVE tEE TEE-Guided Complex Valve Repair Applications for TEE While on Cardiopulmonary Bypass 3D TEE Utility in Extremely Challenging Cases
Register onl ine today at scientif icsessions.org. (promo code DM301)
9–10:15 am DRUg-ElUtINg StENtS II: fIRSt- tO thIRD-gENERAtION DES AND clINIcAl tRIAlS
Sirolimus vs Paclitaxel Stents: The Trials Tell Us What? Comparison of Everolimus vs Paclitaxel Stents: The SPIRIT Program Biolimus vs First-Generation DES: The LEADERS and Nobori Programs Endeavor and Endeavor Resolute: Superior Prevention of Very Late Stent Thrombosis? Can We Choose the Right DES for a Particular Patient? A Case Study
10:45 am–NOON pERcUtANEOUS StRUctURAl hEARt INtERVENtIONS: cASE REVIEW WIth thE ExpERtS (ASk thE ExpERtS)
Case 1: Pulmonary Valve Implantation Case 2: Repairing a Paravalvular Leak Case 3: Coronary Occlusion During TAVI Case 4: Valve in Valve Implant for a Failed Prosthesis
2–3:15 pm MODERAtE AND SEVERE cORONARY StENOSIS: StENt, MEDIcAtION OR VIRtUAl hIStOlOgY?
Severe Stenosis Predicts Infarction and Is a Revascularization Target Severe Stenosis Does Not Predict MI: Physiology Dictates Stenting Physiology and Stenosis Severity Still Don’t Matter: Medical Therapy
Prevents MI Stenosis, Physiology and Medications Are Not Enough: Vulnerable Plaque
Must Be Identified Bioabsorbable Stents and Vulnerable Plaque: Will They Change the
Treatment Algorithms?
REVAScUlARIZAtION IN hIgh-RISk pAtIENtS Revascularization Decisions: Stenosis vs Physiology Revascularization in Diabetic Patients: Lessons from SYNTAX and BARI, Expectations from FREEDOM Revascularization Choices and Left Main Artery Disease Viability, Support Devices and Revascularization in Patients with Poor Left
Ventricular Function PCI for STEMI: New Pharmacology and Improvements in Mortality
3:45–5 pm ENDOVAScUlAR cOMplIcAtIONS AND chAllENgES: cASE REVIEW WIth thE ExpERtS (ASk thE ExpERtS)
A Bad Case of Embolization Complex Renal Artery Intervention A Case of a Hostile Neck My Worst Complication in 2010
5:30–6:45 pm cAROtID StENtINg IN 2010 Does Today’s Stroke Rate in Asymptomatic Carotid Arteries Mandate Any
Kind of Intervention? The Future Is Now: Emboli Protection for 2010 and Beyond Common Pitfalls and Complications: A Case-Based Survey CREST: Reinforcing Biases or Charting a New Course? A Case Study in Complex Carotid Stenting
tRANScAthEtER VAlVE thERApIES AVR Transfemoral Approach AVR Transapical Approach Transcatheter Mitral Repair Devices Transcatheter Mitral Valve Replacement Computational Fluid Dynamics Considerations
Join or renew your AhA/ASA professional Membership today and save! (promo code DAJ103ZZ)
Register onl ine today at scientif icsessions.org. (promo code DM301)
hEpARIN-INDUcED thROMBOcYtOpENIA: NEW cONcEptS AND NEW ANtIcOAgUlANtS
New Concepts About Pathophysiology Patients at Risk: Interpreting HIT Tests Implications of Thrombocytopenia in Cardiovascular Disease Intraoperative Strategies for the HIT Patient Postoperative Management: Current Strategies
7–9 pm REVAScUlARIZAtION IN ISchEMIc hEARt DISEASE How to Choose Between BMS and DES Decision Making in Chronic Total Obstruction Contemporary CABG: Pump and Conduit Choices The Diabetic Patient
StROkE thERApY: MOVINg INtO thE INtERVENtIONAl AgE Extending the Time Window for Acute Stroke Thrombolysis Mechanical Embolectomy Carotid Revascularization: Stenting vs Endarterectomy Intracranial Angioplasty
tUESDAY, NOVEMBER 16
7:45–8:45 am cONtEMpORARY StRAtEgIES fOR cOMplEx UNIVENtRIcUlAR cONgENItAl lESIONS
hOW tO OptIMAllY REpAIR thE DEgENERAtIVE MItRAl VAlVE Leaflet Resection Leaflet Preservation and Imbrication Neochordal Construction
hOW tO SUccEED IN INfRApOplItEAl INtERVENtION Indications for Intervention Rather than Surgery Case 1: Atherectomy, Balloons and Stents Case 2: DES and Drug-Eluting Balloons
9–10:15 am thE BESt Of INtERVENtIONAl cARDIOlOgY fROM Acc,ESc AND tct 2010
The 3 Best PCI Trials of 2010 The 3 Best Trials in Endovascular Interventions 2010 The 3 Best Trials in Structural Heart Interventions 2010 Not Trials, But the 3 Most Important Registry Studies of 2010 Not Trials and Not Registries, but the 3 Most Important Translational
Science PCI Findings in 2010
10:45 am–NOON pcI cOMplIcAtIONS AND chAllENgES: cASE REVIEW WIth thE ExpERtS (ASk thE ExpERtS)
A Case of Complex Left Main Stenting A Case of Large Thrombus Burden My Worst Complication in 2010 A Case of Dissection and Side Branch Occlusion During Bifurcation Stenting
2–3:15 pm pfO, StROkE AND MIgRAINES: EVAlUAtION, cONtROVERSY AND tREAtMENt Evaluation of Cryptogenic Stroke Migraines and PFO: What Is the Evidence? The MIST and CLOSURE Trials: What Have We Learned? PFO and Migraine Trials: What’s Next? PFO Closure: New Devices on the Horizon A Closure Case Study: Challenges and Tricks
Join or renew your AhA/ASA professional Membership today and save! (promo code DAJ103ZZ)
2– 3:15 pm thORAcIc AORtIc DISEASE: NEW gUIDElINES, NOVEl thERApIES What Size and What Method? Thoracic Aneurysm Repair Timing by the Guidelines Standard Practice and Recent Insights: Acute Management of Aortic Dissection Percutaneous Management of Aortic Dissection in 2010 Standard of Care for Thoracic Aortic Atheroembolism The Impact of Genetics on the Management of Thoracic Aortic Disease
3:45–5 pm cURRENt chAllENgES IN IlIOfEMORAl INtERVENtIONS Iliofemoral Stent Restenosis: Incidence, Diagnosis and Treatment Strategy The 15-cm SFA Total Occlusion: Stents, Atherectomy or Just Angioplasty? A Severe Femoral Stenosis: Indication for Surgery or Atherectomy? Will Drug-Eluting Balloons Be the Next Great Leap Forward? Complex Iliofemoral Case Study and Panel Discussion
5:30–6:45 pm pERcUtANEOUS cIRcUlAtORY SUppORt DEVIcES INcARDIOgENIc ShOck
Hemodynamics of Heart Failure in the Catheterization Laboratory Clinical Applications of Percutaneous LVAD in Decompensated Heart
Failure and Shock Case Study 1: Percutaneous Left Ventricular Support Case Study 2: Right Ventricular Support in Cardiogenic Shock Troubleshooting and Complications of Percutaneous Circulatory
Support Devices
thORAcIc AORtIc SURgERY ADVANcES When to Replace the Ascending Aorta in Bicuspid Aortic Valve Disease Endograft Stenting of the Descending Aorta During Operative Type A
Dissection Repair TAAA Repair: What Have We Learned After 2,000 Cases? Extreme Hybrid Arch and TAAA Endografting Neuroprotection Advances
YOUNg cARDIOVAScUlAR SURgEONS AND ANESthESIOlOgIStS cOMMIttEE fORUM
Classic Training Pathway Alternate Training Pathways: Fast-Track and Integrated Starting Out: Operate Like Crazy Starting Out: Secure a Grant Managing Industry Relationships
MANAgEMENt Of cAROtID ARtERY DISEASE: ENDARtEREctOMY VS. StENtINg Update on CREST What Was It Like to Chair the CREST DSMB for 10 Years? Update on International Carotid Stenting Trial Implications for Carotid Stenting Implications for Carotid Endarterectomy
WEDNESDAY, NOVEMBER 17
7:45–8:45 am hOW tO REpAIR thE AORtIc VAlVE Valve-Sparing Aortic Root Replacement Leaflet Repair Repairing the Bicuspid Aortic Valve
Register onl ine today at scientif icsessions.org. (promo code DM301)
9–10:15 am pcI fOR SAphENOUS VEIN gRAft DISEASE: StAtE Of thE ARt Pathophysiology of Saphenous Vein Graft Failure Treatment of Intermediate Saphenous Vein Graft Lesions: DES or Medicine or Both? Embolic Protection Devices: Which Patients, Which Devices? Drug-Eluting or Bare Metal Stents for Vein Grafts? Complex Vein Graft PCI: A Case Study and Panel Discussion
10:45–NOON AcUtE StEMI: DEfININg thE BESt SYStEM Of cARE Acute STEMI: Can We Predict the Culprit Lesion? STEMI Algorithms over the Past Decade: Are We Saving Lives? Patients Presenting to Non-PCI Centers: What Should We Do? STEMI in Urban Areas: Systems of Care STEMI PCI Adjunctive Therapy: Is There a Simple Algorithm?
2–3:15 pm hEARt fAIlURE: EMERgINg IMAgINg MODAlItIES, StRAtEgIES AND thERApIES
Multimodality Imaging to Identify the Optimal Therapy (Revascularization, Remodeling, Replacement)
Emerging Concepts in Cardiac Tissue Engineering Catheter-Based Stem Cell Therapy for the Failing Heart: Where Are We Going? Cutting Edge Surgery for the Failing Heart: A New STITCH or Jacket? Novel VAD Technology, Implantable RVAD and the Next Total Artificial Heart
■ fAcUltY — cORE 1 AND cORE 6
Domestic
A Marc gillinov, Cleveland, OH
Aasha gopal, Roslyn, NY
Adnan I Qureshi, Minneapolis, MN
Albert cheung, Philadelphia, PA
Alberto pochettino, Philadelphia, PA
Allen taylor, Washington, DC
Amgad Makaryus, New Hyde Park, NY
Andreas kalogeropoulos, Atlanta, GA
Annapoorna kini, New York, NY
Anthony N DeMaria, San Diego, CA
Anthony Rosenzweig, Boston, MA
Antoinette gomes, Los Angeles, CA
Arnar geirsson, New Haven, CT
Barry Borlaug, Rochester, MN
Bartley p griffith, Baltimore, MD
Bernard J gersh, Rochester, MN
Bernhard Meier, Bern, Switzerland
Bijoy k khandheria, Milwaukee, WI
Blase A carabello, Houston, TX
Bonnie Milas, Philadelphia, PA
carmelo Milano, Durham, NC
catherine M Otto, Seattle, WA
cathy A Sila, Cleveland, OH
charanjit S Rihal, Rochester, MN
charles J Bruce, Rochester, MN
christopher J cooper, Toledo, OH
christopher M kramer, Charlottesville, VA
christopher White, New Orleans, LA
chun Yuan, Seattle, WA
clyde W Yancy, Dallas, TX
constantine Mavroudis, Cleveland, OH
constantino S pena, Miami, FL
craig Smith, New York, NY
Daniel S Berman, West Hollywood, CA
David A Bluemke, Bethesda, MD
David cohen, Kansas City, MO
David E kandzari, La Jolla, CA
David E Sosnovik, Charlestown, MA
David holmes, Rochester, MN
David J Sahn, Portland, OR
David Maron, Nashville, TN
David R holmes, Rochester, MN
Deepak Bhatt, Boston, MA
Dianna Milewicz, Houston, TX
Dominick J Angiolillo, Jacksonville, FL
Donald E cutlip, Boston, MA
Doris A taylor, Minneapolis, MN
Douglas Drachman, Boston, MA
Douglas losordo, Chicago, IL
Edward l Bove, Ann Arbor, MI
Edward Mcfalls, Minneapolis, MN
Elaine tseng, San Francisco, CA
Elliott Antman, Boston, MA
Elyse foster, San Francisco, CA
Emin Murat tuzcu, Cleveland, OH
Emmanouil Brilakis, Dallas, TX
Eric Michael Isselbacher, Boston, MA
Eric R Bates, Ann Arbor, MI
Erik Magnus Ohman, Durham, NC
Ernest V garcia, Atlanta, GA
frank Bengel, Baltimore, MD
frank Sellke, Providence, RI
frans J Wackers, New Haven, CT
frederick Ruberg, Boston, MA
gary Ansel, Columbus, OH
gary D Webb, Cincinnati, OH
gary S Roubin, New York, NY
gary V heller, Hartford, CT
george D Dangas, New York, NY
gerry Buckberg, Los Angeles, CA
gorav Ailawadi, Charlottesville, VA
gordon Depuey, New York, NY
grayson Wheatley, Phoenix, AZ
gregg W Stone, New York, NY
harold Dauerman, Burlington, VT
hartzell Schaff, Rochester, MN
heather gornik, Cleveland, OH
howard c herrmann, Philadelphia, PA
Ik-kyung Jang, Boston, MA
Ileana piña, Cleveland, OH
Issam Moussa, New York, NY
Itzhak kronzon, New York, NY
J V (Ian) Nixon, Richmond, VA
Join or renew your AhA/ASA professional Membership today and save! (promo code DAJ103ZZ)
J Michael DiMaio, Dallas, TX
Jack A Ziffer, Miami, FL
Jagat Narula, Orange, CA
Jagmeet p Singh, Boston, MA
James D Marsh, Little Rock, AR
James D thomas, Cleveland, OH
James E Udelson, Boston, MA
James k Min, New York, NY
James p Zidar, Durham, NC
Jeff Moses, NY
Jeffrey l Saver, Los Angeles, CA
Jennifer h Mieres, New York, NY
Jennifer lawton, St Louis, MO
Jennifer tremmel, Stanford, CA
Jerrold h levy, Atlanta, GA
Joao A lima, Baltimore, MD
Joe Woo, Philadelphia, PA
Johannes Bonatti, Baltimore, MD
John Augoustides, Philadelphia, PA
John carr, Winston-Salem, NC
John D carroll, Littleton, CO
John E Aruny, New Haven, CT
John g Byrne, Nashville, TN
John gorcsan, Pittsburgh, PA
John Ikonomidis, Charleston, SC
John Rhodes, Durham, NC
John Spertus, Kansas City, MO
Jonathan lindner, Portland, OR
Jose g Romano, Miami, FL
Joseph M garasic, Boston, MA
Joseph S coselli, Houston, TX
Joseph Sabik, Cleveland, OH
Joshua A Beckman, Boston, MA
Judith hochman, New York, NY
Judy Mangion, Boston, MA
kanishka Ratnayaka, Washington, DC
katherine Wu, Baltimore, MD
kenneth Rosenfield, Boston, MA
kim A Eagle, Ann Arbor, MI
lars Svensson, Cleveland, OH
laura Mauri, Boston, MA
lawrence A garcia, Boston, MA
lawrence M Boxt, Bronx, NY
leon Axel, New York, NY
leslee Shaw, Atlanta, GA
linda Shore-lesserson, Bronx, NY
loren f hiratzka, Cincinnati, OH
Manesh R patel, Hillsborough, NC
Mani A Vannan, Columbus, OH
Marcelo f Dicarli, Boston, MA
Marco costa, OH
Margaret M Redfield, Rochester, MN
Mariell Jessup, Philadelphia, PA
Mark h Wholey, Pittsburgh, PA
Mark haigney, Bethesda, MD
Mark I travin, Bronx, NY
Mark Reisman, Seattle, WA
Mark S Slaughter, Louisville, KY
Martin S Maron, Boston, MA
Matthew Menard, Boston, MA
Matthias Nahrendorf, Boston, MA
Maurice E Sarano, Rochester, MN
Mauricio cohen, Miami, FL
Michael A Acker, Philadelphia, PA
Michael Argenziano, New York, NY
Michael c kontos, Richmond, VA
Michael fischbein, Stanford, CA
Michael h kim, New York, NY
Michael h picard, Boston, MA
Michael hansen, Bethesda, MD
Michael J Rinaldi, Charlotte, NC
Miguel Quinones, Houston, TX
Mitchell krucoff, Durham, NC
Monvadi B Srichai, Brooklyn, NY
Myron gerson, Cincinnati, OH
N A Mark Estes III, Boston, MA
Nancy Nussmeier, Syracuse, NY
Navin k kapur, Boston, MA
Nimesh D Desai, Philadelphia, PA
Niv Ad, Falls Church, VA
Noel c Bairey-Merz, Los Angeles, CA
O howard frazier, Houston, TX
pamela Woodard, St Louis, MO
panithaya chareonthaitawee, Rochester, MN
parag patel, Milwaukee, WI
patricia thistlethwaite, San Diego, CA
patrick M Mccarthy, Chicago, IL
patrick t O’gara, Boston, MA
paul S teirstein, La Jolla, CA
pavan Atluri, Philadelphia, PA
pedro J Del Nido, Boston, MA
peter Berger, Danville, PA
prediman k Shah, Los Angeles, CA
prem Shekar, Boston, MA
Rakesh Suri, Rochester, MN
Ralph Damiano, St Louis, MO
Ramachandran Vasan, Framingham, MA
Raymond J gibbons, Rochester, MN
Raymond J kim, Durham, NC
Raymond kwong, Boston, MA
Rebecca t hahn, New York, NY
Reed A Omary, Chicago, IL
Renu Virmani, Gaithersburg, MD
Ricardo c cury, Miami, FL
Richard Becker, Durham, NC
Richard george, Baltimore, MD
Richard Jonas, Washington, DC
Richard kim, New Haven, CT
Robert A guyton, Atlanta, GA
Robert A lookstein, New York, NY
Robert Bersin, Seattle, WA
Robert gorman, Glenolden, PA
Robert harrington, Durham, NC
Robert hendel, Miami, FL
Robert J Applegate, Winston-Salem, NC
Robert J lederman, Bethesda, MD
Robert l frye, Rochester, MN
Robert O Bonow, Chicago, IL
Robert Siegel, West Hollywood, CA
Roberto lang, Chicago, IL
Rohinton Morris, Philadelphia, PA
Roxana Mehran, New York, NY
Samir kapadia, Cleveland, OH
Sander connolly, New York, NY
Sanjay Rajagopalan, OH
Scott D Solomon, Boston, MA
Sharon l Mulvagh, Rochester, MN
Sharonne N hayes, Rochester, MN
Sherif f Nagueh, Houston, TX
Smadar kort, Stony Brook, NY
Sriram S Iyer, New York, NY
Stanton Shernan, Boston, MA
Stephen J green, Manhasset, NY
Steven E Nissen, Cleveland, OH
Steven lester, Scottsdale, AZ
Steven Sedlis, New York, NY
Subha Raman, Columbus, OH
Sunil V Rao, Durham, NC
t Reece, Aurora, CO
ted feldman, Evanston, IL
teresa carman, Cleveland, OH
theodore Abraham, Baltimore, MD
thomas c gerber, Jacksonville, FL
thomas g Brott, Jacksonville, FL
thomas Marwick, Cleveland, OH
thomas Ryan, Columbus, OH
timothy J gardner, Newark, DE
■ fAcUltY — cORE 1 AND cORE 6
Domestic (continued)
Register onl ine today at scientif icsessions.org. (promo code DM301)
Adam torbicki, Warsaw, Poland
Alaide chieffo, Milan, Italy
Alain carpentier, Paris, France
Angelo Auricchio, Lugano, Switzerland
Barbara Mulder, Amsterdam, Netherlands
Boris hoffmann, Hamburg, Germany
Brian Buxton, Richmond, Vic, Australia
Bruno Scheller, Homburg Saar, Germany
carlo Vigna, San Giovanni Rotondo (FG), Italy
cheuk-Man Yu, Hong Kong, China
D leung, Liverpool, Australia
Dariusz Dudek, Krakow, Poland
Don poldermans, Rotterdam, Netherlands
Eberhard grube, Essen, Germany
frank Rademakers, Leuven, Belgium
friedrich Mohr, Leipzig, Germany
gebrine El khoury, Brussels, Belgium
genevieve Derumeaux, Lyon, France
gilles Montalescot, Paris, France
giuseppe De luca, Novara, Italy
hans-Joachim Schaefers, Homburg Saar, Germany
harvey White, Auckland, New Zealand
helene Eltchaninoff, Rouen, France
horst Sievert, Frankfurt, Germany
J l Zamorano, Madrid, Spain
Jan f gummert, Bad Oeynhausen, Germany
Jean fajadet, Toulouse, France
Jeanette Schulz-Menger, Berlin, Germany
Jeffrey Weitz, Hamilton, Canada
Jeroen Bax, Leiden, Netherlands
Joanne D Schuijf, Leiden, Netherlands
John Webb, Vancouver, Canada
Jose henriques, Amsterdam, Netherlands
Josep Rodés-cabau, Quebec, Canada
Joseph Selvanayagam, Bedford Park, Australia
Juhani knuuti, Turku, Finland
Julinda Mehilli, Munich, Germany
keith A fox, Edinburgh, United Kingdom
klaus Mathias, Dortmund, Germany
kurt huber, Vienna, Austria
Marc Ruel, Ottawa, Canada
Marie Morice, Massy, France
Mark Eisenberg, Montreal, Canada
Markku kaste, Helsinki, Finland
Marla kiess, Vancouver, Canada
Martin Schalij, Leiden, Netherlands
Martin Schillinger, Vienna, Austria
Matthias g friedrich, Calgary, Canada
Mauro carlino, Milano, Italy
Mina Madan, Toronto, Canada
Nina Ajmone Marsan, Leiden, Netherlands
Olivier Bertrand, Quebec, Canada
p A tonino, Eindhoven, Netherlands
patrick W Serruys, Rotterdam, Netherlands
petros Nihoyannopoulos, London, United Kingdom
philipp kaufmann, Zurich, Switzerland
philippe pibarot, Quebec, Canada
philippe Steg, Paris, France
pierre Amarenco, Paris, France
Raimund Erbel, Essen, Germany
Raoul Bonan, Montreal, Canada
Reza Razavi, London, United Kingdom
Rob Beanlands, Ottawa, Canada
Roland hetzer, Berlin, Germany
Ross Naylor, Leicester, United Kingdom
Seung-Jung park, Seoul, South Korea
Shinichi Osaka, Chiba Prefecture, Japan
Shinichi takamoto, Tokyo, Japan
Shuichi Saito, Fukushima, Japan
Song Wan, Hong Kong, China
Stefan k James, Uppsala, Sweden
Stephan h Duda, Tubigen, Germany
Stephan Windecker, Bern, Switzerland
thierry lefevre, Massy, France
taweesak chotivatanapong, Bangkok, Thailand
thomas Zeller, Bad Krozingen, Germany
Victoria Delgado, Leiden, Netherlands
William Wijns, Aalst, Belgium
Yee Eot chee, Hong Kong, China
■ fAcUltY — cORE 1 AND cORE 6
International
■ fAcUltY — cORE 1 AND cORE 6
Domestic (continued)timothy henry, Minneapolis, MN
tony Das, Dallas, TX
Udo hoffmann, Boston, MA
Valentin fuster, New York, NY
Vasken Dilsizian, Baltimore, MD
Verghese Mathew, Rochester, MN
Victor A ferrari, Philadelphia, PA
Victor f tapson, Durham, NC
Vincent B ho, Bethesda, MD
Vinod h thourani, Atlanta, GA
Viola Rieke, Stanford, CA
Vivek Y Reddy, Boston, MA
Wade Smith, San Francisco, CA
William A gray, New York, NY
William c little, Winston-Salem, NC
William cohn, Houston, TX
William fearon, Stanford, CA
William hundley, Winston-Salem, NC
William t Abraham, Columbus, OH
William Zoghbi, Houston, TX
Wolfgang A k Radtke, Wilmington, DE
Y Joseph Woo, Philadelphia, PA
Zahi fayad, New York, NY
Ziyad hijazi, Chicago, IL
Join or renew your AhA/ASA professional Membership today and save! (promo code DAJ103ZZ)
■ cONtINUINg EDUcAtION AccREDItAtION
Physicians, physician assistants, nurses and pharmacists may earn continuing education credits at Scientific Sessions. For full CME/CE accreditation information, visit scientificsessions.org.
■ ScIENcE & tEchNOlOgY hAll
Get hands-on learning in the Science & Technology Hall, where you’ll find information and demonstrations on the latest cardiovascular technology, drugs and resources from more than 300 companies.
Science & technology hall hours
Sunday, Nov 14, 11 am–5 pm Unopposed Hours: Lunch & Learn, 11:30 am–1:30 pm, and Breaks
Monday, Nov 15, 9 am–5 pmUnopposed Hours: Lunch & Learn, Noon–2 pm, and Breaks
Tuesday, Nov 16, 9 am–2:30 pmUnopposed Hours: Lunch & Learn, Noon–2 pm, and Breaks
■ ExpERIENcE REgIStRAtION SAVINgS AS AN AhA/ASA pROfESSIONAl MEMBER!
Advance your career by becoming a member of the Council on Cardiovascular Radiology and Intervention and save up to $370* on your Scientific Sessions registration fees.
*Registration savings depend on membership tier. **Visit scientificsessions.org for a full list of registration categories and rates. ***Must join or renew by Sept. 30, 2010
JOIN OR RENEW tODAY! Visit my.americanheart.org and click on member services or americanheart.org/cvricouncil to learn more. (Use Promo Code DAJ103ZZ)
2010 Registration Rates**
Registration typesAdvance Rate Until Oct. 15
On-site Rate After Oct. 15
premium professional Member*** $395 $495
Nonmember $765 $865
“�Council�membership�has�provided�me�the�opportunity�to�interact�with�like-minded�colleagues�in�various�disciplines�and�has�enriched�my�professional�career.”
Arthur E. Stillman, MD, PhD, FAHA
Register onl ine today at scientif icsessions.org. (promo code DM301)
■ cOUNcIl ON cARDIOVAScUlAR RADIOlOgY AND INtERVENtION ActIVItIES At SESSIONS
MElVIN JUDkINS YOUNg clINIcAl INVEStIgAtOR AWARD
Sponsored by the CVRI Council, this award is named for the pioneer of coronary angiography. The award recognizes meritorious research and promotes careers in cardiovascular radiology. Candidates for the award are early career investigators pursuing research in the basic biological or medical sciences.
Five finalists for the 2010 award will present their research in an oral abstract session at Sessions. The competition will take place on Sunday, Nov 14, at 3:45 pm, at the McCormick Place Convention Center.
chARlES t DOttER MEMORIAl lEctURE
The CVRI Council established the lecture in 1987 in honor of Charles T. Dotter, who contributed significantly to the evaluation of cardiovascular angiography and who pioneered the development of angioplasty and other interventional cardiovascular procedures.
This year’s presenter is John Kaufman, M.D., chief of Vascular & Interventional Radiology at Oregon Health & Sciences University. The lecture will take place on Tuesday, Nov. 16, at 2:00 pm, at the McCormick Place Convention Center.
cVRI ANNUAl DINNER, AWARDS pRESENtAtION, AND ANNUAl BUSINESS MEEtINg
tuesday, Nov 16, 7 pm hyatt Regency chicago $50 on or before Oct 15, $60 after Oct 15
Bring your nonmember peers and encourage them to join cVRI!
The first 30 minutes of the dinner will feature a “meet the members” designated time for nonmembers of the CVRI Council to mingle with and get to know CVRI members.
the following will be recognized at the dinner:
• Melvin Judkins Young Investigator Finalists and Winner
• Charles T Dotter Memorial Lecturer: John Kaufman, Portland, Ore.
EARlY cAREER INVEStIgAtOR tRAVEl gRANt WINNERS
The CVRI Early Career Investigator Travel Stipends support the efforts of outstanding early career investigators and encourage their participation in council and AHA activities. These stipends annually provide funding to early career investigators to attend Sessions, where their research has been accepted for presentation
7272
Gre
envi
lle A
ve. D
alla
s, T
X 7
5231
-459
6
scie
ntificsessio
ns.o
rg
Exhib
its: N
ovem
ber
14
–16
Sessio
ns: N
ovem
ber
13
–17
Resuscitation S
cie
nce S
ym
posiu
m: N
ovem
ber
13
–14
Chic
ago, Illinois
scientificsessions.org
©20
10 A
mer
ican
Hea
rt A
ssoc
iatio
n. 7
/10K
B00
93
1. V
isit
htt
p:/
/ww
w.g
ett
ag
.mo
bi
on y
our
Sm
artp
hone
.
2. D
ownl
oad
the
free
mob
ile a
pp
.
3. U
sing
the
app,
hov
er y
our
phon
e
over
the
col
ored
box
. It
will
the
n op
en th
e C
ore
One
Web
pag
e.
MO
BIL
E T
AG
S A
T S
CIE
NT
IFIC
SE
SS
ION
S
Get
the
free
app
for y
our p
hone
at
http://ge
ttag
.mob
i
S N A P I T
Regi
ster o
nlin
e to
day
and
disc
over
ca
rdio
vasc
ular
imag
ing
and
vasc
ular
dise
ase
prog
ram
min
g at
Sci
entifi
c Se
ssio
ns.